Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks

Description

The purpose of this study is to determine whether using the P3P website can increase decisional preparation and satisfaction, and decrease decisional conflict, in men deciding how to manage early stage prostate cancer.

Study Start Date

September 2013

Estimated Completion Date

August 2016

Interventions

  • Behavioral: Standard prostate cancer information websites
  • Behavioral: Personal Patient Profile - Prostate (P3P)

Specialties

  • Urology: Oncology,Prostate
  • Oncology: Renal/Urologic

MeSH Terms

  • Prostate Cancer
  • Prostatic Neoplasms

Study ID

Dana-Farber Cancer Institute -- 12-363

Status

Unknown

Trial ID

NCT01844999

Study Type

Interventional

Trial Phase

Phase 3

Enrollment Quota

625

Sponsor

Dana-Farber Cancer Institute

Inclusion Criteria

  • Biopsy-proven diagnosis of prostate cancer, T1 or T2 of any risk level
  • Biopsy done at enrolling site
  • Upcoming appointment with consulting specialist at enrolling study site
  • Able to read, write, understand English

Exclusion Criteria

  • Two or more post-biopsy specialist consults
  • Begun treatment (or active surveillance)

Gender

Male

Ages

18 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Beth Israel Deaconess Medical Center - Boston, Massachusetts 2.6 miles Catrina Crociani None ccrociani@bidmc.harvard.edu

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.